ATRICURE GETS EU APPROVAL FOR CARDIAC DEVICE

AtriCure Inc. said Sunday that it has received the European Union's CE Mark approval to market its cardiac device for the treatment of cardiac arrhythmias. The approval of the Isolator Transpolar System includes the treatment of atrial fibrillation, AtriCure said in a news release.
Cincinnati Business Courier